Ash Blythe Alpert, MD, MFA
Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Member, Cancer Prevention and Control
Contact Info
Yale Cancer Center
333 Cedar Street, PO Box 208028
New Haven, Connecticut 06520
United States
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Member, Cancer Prevention and Control
Contact Info
Yale Cancer Center
333 Cedar Street, PO Box 208028
New Haven, Connecticut 06520
United States
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileAdditional Titles
Member, Cancer Prevention and Control
Contact Info
Yale Cancer Center
333 Cedar Street, PO Box 208028
New Haven, Connecticut 06520
United States
About
Titles
Instructor
Member, Cancer Prevention and Control
Biography
Ash Alpert, MD, MFA, (pronouns they/them) is an Instructor of Medicine (Hematology). Dr. Alpert completed their post-doctoral fellowship (T32) in health services research at the Brown University School of Public Health.
Dr. Alpert received their medical degree from the University of Vermont Larner College of Medicine and completed residency at Cambridge Hospital and fellowship in Hematology and Medical Oncology at the Wilmot Cancer Institute of the University of Rochester Medical Center. Their research and scholarship focuses on improving experiences and outcomes for transgender people with hematologic disease or cancer, and they work with a community advisory board of transgender people diagnosed with cancer with whom they have conducted research and published research and scholarship for over five years.
They received a Young Investigator Award from Conquer Cancer, the American Society for Clinical Oncology (ASCO) Foundation to develop patient-centered and non-stigmatizing gender identity data collection methods to be implemented in oncology settings and investigate the connections between experiences of violence and cancer risk for transgender people. Dr. Alpert is also involved with advocacy efforts nationally including working with national oncology organizations such as the National Comprehensive Cancer Network and ASCO to implement structural changes to improve outcomes for transgender people with cancer.
Appointments
Hematology
InstructorPrimary
Other Departments & Organizations
Education & Training
- MD
- University of Vermont Larner College of Medicine (2014)
- MFA
- Western Michigan University (2004)
- BA
- Oberlin College (1998)
Research
Overview
Dr. Alpert's research investigates community solutions to improving the experiences and outcomes of transgender people with cancer. They received a Young Investigator Award from Conquer Cancer, the American Society for Clinical Oncology (ASCO) Foundation to develop patient-centered and non-stigmatizing gender identity data collection methods to be implemented in oncology settings and investigate the connections between experiences of violence and cancer risk for transgender people.
ORCID
0000-0003-1736-898X
Research at a Glance
Yale Co-Authors
Publications Timeline
John Pachankis, PhD
Marcella Nunez-Smith, MD, MHS
Robin Dembroff
Publications
2024
Disentangling gender, sex, and biology: a mixed methods study of gender identity data collection tools
Alpert A, Hernandez T, Ruddick R, Manzano C, Adams S, Rivers L, Ramos-Pibernus A, Sevelius J, Poteat T, Obedin-Maliver J, Cicero E, Radix A, Lett E, Operario D, Chapman B, Wittink M, Cupertino A, Murchison G, Nunez-Smith M, Cartujano-Barrera F. Disentangling gender, sex, and biology: a mixed methods study of gender identity data collection tools. Patient Education And Counseling 2024, 130: 108473. PMID: 39471780, DOI: 10.1016/j.pec.2024.108473.Peer-Reviewed Original ResearchConceptsTGD peopleGender identity questionTGD participantsConflation of sexConcepts of sexIdentical questionsTGD adultsGender identityCommunity membersTGDContextual factorsQualitative dataGenderDecrease stigmaPeopleData collection toolTemplate analysisQuantitative dataAnalyzed quantitative dataCisgenderismCollective preferencesQuestionsTransgenderMedical careMixing methodDoes cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people?
Alpert A, Obedin-Maliver J, Gjelsvik A, Amanullah S, Shireman T, Blosnich J. Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people? Contemporary Clinical Trials 2024, 146: 107695. PMID: 39303766, DOI: 10.1016/j.cct.2024.107695.Peer-Reviewed Original ResearchConceptsBehavioral Risk Factor Surveillance SurveyCancer clinical trial enrollmentClinical trial enrollmentTrial enrollmentRisk Factor Surveillance SurveySGM peopleNon-SGM individualsClinical trial participationCancer disparitiesSurveillance SurveyReport participationGender minority peopleTrial participantsSGM statusSGM individualsPartnership statusLogistic regressionCisgender peopleData collection methodsEnrollmentOncological treatmentOddsMinority peopleParticipantsSGMAssociations between violence, distress, and cancer in transgender and non-transgender people.
Alpert A, Sayegh S, Cunliffe S, Sevelius J, Operario D, Pachankis J, Irwin M, Cerulli C, Griggs J, Strawderman M. Associations between violence, distress, and cancer in transgender and non-transgender people. Journal Of Clinical Oncology 2024, 42: 10566-10566. DOI: 10.1200/jco.2024.42.16_suppl.10566.Peer-Reviewed Original ResearchAltmetricConceptsCancer risk factorsDiagnosis codesRisk factorsRates of violenceElectronic medical record dataTransgender peopleCross-sectional cohort studyMedical record dataGender identity informationGender identityIncreased cancer morbidityBias-corrected bootstrap confidence intervalsAssess distressProbability of cancerScreening questionsCancer riskCancer morbidityChi-square testComparison of violenceExperiences of violenceCohort studyAcademic hospitalVariable of violenceIndirect pathsRecord dataDoing Justice: Ethical Considerations Identifying and Researching Transgender and Gender Diverse People in Insurance Claims Data
Alpert A, Babbs G, Sanaeikia R, Ellison J, Hughes L, Herington J, Dembroff R. Doing Justice: Ethical Considerations Identifying and Researching Transgender and Gender Diverse People in Insurance Claims Data. Journal Of Medical Systems 2024, 48: 96. PMID: 39394534, PMCID: PMC11469973, DOI: 10.1007/s10916-024-02111-w.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsTGD individualsSelf-identificationHealth of transgenderGender diverse peopleGender self-identificationTGD peopleTGD populationsDiverse peopleEpistemic injusticeTransgenderTGDGenderHealth researchHealth services researchEthical complexitiesPeopleServices researchClaims-based algorithmInjusticeInsuranceHealthIndividualsEthical considerationsResearchClaims
2023
Prevalence and correlates of current cigarette smoking among transgender women in Argentina
Cartujano-Barrera F, Mejia R, Radusky P, Cardozo N, Duarte M, Fabian S, Caballero R, Zalazar V, Ramos-Pibernus A, Alpert A, Cupertino A, Frola C, Aristegui I. Prevalence and correlates of current cigarette smoking among transgender women in Argentina. Frontiers In Public Health 2023, 11: 1279969. PMID: 38115852, PMCID: PMC10728477, DOI: 10.3389/fpubh.2023.1279969.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsGender identity stigmaCurrent cigarette smokingTransgender womenIdentity stigmaAssociated with current cigarette smokingHistory of sex workSubstance useCigarette smokingHazardous drinkingBuenos AiresPrevalence of current cigarette smokingPerceived health statusSexual violenceTransgender individualsSmoking cessation interventionsBaseline dataSex workCisgender womenAssociated with educationSecondary data analysisProspective cohort studyPoliceHazardous alcohol drinkingLogistic regression modelsCessation interventionsTransgender People’s Experiences Sharing Information With Clinicians: A Focus Group–Based Qualitative Study
Alpert A, Mehringer J, Orta S, Hernandez T, Redwood E, Rivers L, Manzano C, Ruddick R, Adams S, Sevelius J, Belanger E, Operario D, Griggs J. Transgender People’s Experiences Sharing Information With Clinicians: A Focus Group–Based Qualitative Study. The Annals Of Family Medicine 2023, 21: 408-415. PMID: 37748898, PMCID: PMC10519763, DOI: 10.1370/afm.3010.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCommunity-based participatory research approachFocus groupsSafety of clinical careTransgender peopleFamily medicine cliniciansInterpretive description methodologyParticipatory research approachQualitative focus groupsData collection toolSuboptimal careTransgender people's experiencesSubstandard careHealth informationClinical encountersDescriptive methodologyPeer debriefingClinical careClinicians' questionsQualitative studyPurposive samplingMedical cultureCareCommunity membersTransgender adultsMedical systemDebunking Sex and Disentangling Gender From Oncology
Alpert A, Rivers L, Manzano C, Ruddick R, Adams S, Obedin-Maliver J, Harvey R, Griggs J, Operario D. Debunking Sex and Disentangling Gender From Oncology. Journal Of Clinical Oncology 2023, 41: 3791-3795. PMID: 37235816, PMCID: PMC10860932, DOI: 10.1200/jco.22.02037.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsPartnering With Patients and Caregivers in Cancer Care: Lessons From Experiences With Transgender, Hispanic, and Pediatric Populations.
Katz N, Alpert A, Aristizabal M, McDaniels-Davidson C, Sacks B, Sanft T, Chou C, Martinez M. Partnering With Patients and Caregivers in Cancer Care: Lessons From Experiences With Transgender, Hispanic, and Pediatric Populations. American Society Of Clinical Oncology Educational Book 2023, 43: e397264. PMID: 37200592, DOI: 10.1200/edbk_397264.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPediatric populationOncology careFamily-centered careQuality of carePatient populationCancer careCancer morbidityOncology cliniciansClinical trialsEffective patientPatientsCare provisionCancer diagnosisCareHealth careCaregiversCertain populationsUnequal burdenResearch participationCliniciansInequitable accessIndividual needsPopulationMorbidityMortalityThe Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN Content.
Freedman-Cass D, Fischer T, Alpert A, Obedin-Maliver J, Kunz P, Koh W, Carlson R. The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN Content. Journal Of The National Comprehensive Cancer Network 2023, 21: 434-441. PMID: 37156485, DOI: 10.6004/jnccn.2023.7025.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCancer careEquitable cancer careEffective cancer careNCCN Clinical Practice GuidelinesClinical practice guidelinesOptimal oncology careRepresentation of diverse populationsCancer informationOncology careAnti-fat biasPractice guidelinesCareDiverse populationsNCCN GuidelinesGoals of equityNCCNHigh-qualityGuidelinesInclusionSexual orientationInclusive languagePatientsNonstigmatizingIndividualsProfessional contentMethodologic Approaches for Using Electronic Medical Records to Identify Experiences of Violence in Transgender and Cisgender People: Closing the Gap Between Diagnostic Coding and Lived Experiences
Alpert A, Sayegh S, Strawderman M, Cunliffe S, Griggs J, Cerulli C. Methodologic Approaches for Using Electronic Medical Records to Identify Experiences of Violence in Transgender and Cisgender People: Closing the Gap Between Diagnostic Coding and Lived Experiences. Medical Care 2023, 61: 384-391. PMID: 37072686, PMCID: PMC10168107, DOI: 10.1097/mlr.0000000000001852.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsElectronic medical record dataElectronic medical recordsExperiences of violenceCisgender peopleTransgender peopleCisgender cohortRates of violenceMedical recordsImplement effective interventionsCross-sectional studyIdentified violenceStop violenceTransgenderImprove careViolenceScreening questionsCisgenderUpstate New YorkDiagnostic codesEffective interventionsDiagnosis codesRegional referral centerMedical sequelaeMcNemar testCohort
Clinical Care
Overview
Clinical Specialties
Fact Sheets
Lymphoma
Learn More on Yale MedicineHuman Immunodeficiency Virus (HIV)
Learn More on Yale Medicine
Board Certifications
Hematology (Internal Medicine)
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2022
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2017
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews & Links
News
- December 18, 2024
Yale research advances presented at American Society of Hematology annual meeting
- November 18, 2024
Inclusive Care for Transgender People with Cancer & Art as Resistance: Transgender People With Cancer: Film and Panel Discussion
- June 07, 2024
Yale Cancer Center Researchers and Trainees Present at ASCO
- January 25, 2024Source: Journal of Clinical Oncology
Podcast: Debunking Sex and Disentangling Gender From Oncology
Get In Touch
Contacts
Yale Cancer Center
333 Cedar Street, PO Box 208028
New Haven, Connecticut 06520
United States
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.